Ru, Chu-Hui <br/><br/>
Efficacy and Safety of Addition of Anti-PD1 to Chemotherapy in Treatment of Non-Small Cell Lung Cancer.  [electronic resource] 

 -  Combinatorial chemistry & high throughput screening  2018 
 - 711-717 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Review 
<br/><br/><label>ISSN: </label>1875-5402 
<br/><br/><label>Standard No.: </label>10.2174/1386207322666190125150921  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Biomarkers, Tumor--analysis<br/>Carcinoma, Non-Small-Cell Lung--diagnosis<br/>Docetaxel--pharmacology<br/>Humans<br/>Lung Neoplasms--diagnosis<br/>Programmed Cell Death 1 Receptor--analysis